Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nutrition ; 70: 110595, 2020 02.
Article in English | MEDLINE | ID: mdl-31739173

ABSTRACT

OBJECTIVES: The aims of this study were to determine vitamin D status (serum 25-hydroxyvitamin D3 [s-25(OH)D3]) and examine possible associations between vitamin D status and vitamin D-rich dietary sources, sun exposure, and body mass index in preschool children ages 4 to 6 y. METHODS: This is a cross-sectional study based on baseline data (collected in January-February 2015) from the two-armed randomized controlled trial Fish Intervention Studies-KIDS (FINS-KIDS) conducted in Bergen, Norway. S-25(OH)D3 concentration was determined by liquid chromatography-tandem mass spectrometry. Information regarding habitual dietary intake, recent sun vacations, and body mass index were assessed with questionnaires answered by the children's caregivers. RESULTS: The children (n = 212) had a mean (standard deviation) s-25(OH)D3 of 60.7 (13.8) nmol/L; 18.9% had s-25(OH)D3 ≤50 nmol/L. In logistic regression models, non-overweight versus overweight status was inversely associated with s-25(OH)D3 ≤50 nmol/L (odds ratio: 0.41; 95% confidence interval, 0.18-0.95; P = 0.037). Non-sun versus sun vacations were associated with s-25(OH)D3 ≤75 nmol/L (odds ratio: 5.33; 95% confidence interval, 1.93-14.77; P = 0.001). CONCLUSIONS: The majority of the preschool children (81%) had s-25(OH)D3 >50 nmol/L. Children with overweight status had an increased risk of s-25(OH)D3 ≤50 nmol/L, and children who had not been on sun vacations were at a greater risk of s-25(OH)D3 ≤75 nmol/L.


Subject(s)
Calcifediol/blood , Diet/statistics & numerical data , Pediatric Obesity/blood , Vitamin D Deficiency/epidemiology , Vitamin D/analysis , Body Mass Index , Child , Child, Preschool , Cross-Sectional Studies , Diet/adverse effects , Female , Humans , Logistic Models , Male , Norway/epidemiology , Nutritional Status , Pediatric Obesity/complications , Randomized Controlled Trials as Topic , Seasons , Sunlight , Vitamin D Deficiency/blood , Vitamin D Deficiency/etiology
2.
Lipids ; 51(1): 61-73, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26552397

ABSTRACT

The membrane phospholipid composition in mammalian brain can be modified either by nutrients such as dietary fatty acids, or by certain toxic substances such as methylmercury (MeHg), leading to various biological and toxic effects. The present study evaluated the effects of eicosapentaenoic acid (EPA) and MeHg on the composition of the two most abundant membrane phospholipid classes, i.e., phosphatidylcholines (PtdCho) and phosphatidylethanolamines (PtdEtn), in mouse brain by using a two-level factorial design. The intact membrane PtdCho and PtdEtn species were analyzed by liquid chromatography-mass spectrometry. The effects of EPA and MeHg on the PtdCho and PtdEtn composition were evaluated by principal component analysis and ANOVA. The results showed that EPA and MeHg had different effects on the composition of membrane PtdCho and PtdEtn species in brain, where EPA showed strongest impact. EPA led to large reductions in the levels of arachidonic acid (ARA)-containing PtdCho and PtdEtn species in brain, while MeHg tended to elevate the levels of ARA-containing PtdCho and PtdEtn species. EPA also significantly increased the levels of PtdCho and PtdEtn species with n-3 fatty acids. Our results indicate that EPA may to some degree counteract the alterations of the PtdCho and PtdEtn pattern induced by MeHg, and thus alleviate the MeHg neurotoxicity in mouse brain through the inhibition of ARA-derived pro-inflammatory factors. These results may assist in the understanding of the interaction between MeHg, EPA and phospholipids, as well as the risk and benefits of a fish diet.


Subject(s)
Arachidonic Acid/metabolism , Brain/drug effects , Brain/metabolism , Eicosapentaenoic Acid/pharmacology , Methylmercury Compounds/pharmacology , Phospholipids/chemistry , Phospholipids/metabolism , Animals , Dietary Supplements , Eicosapentaenoic Acid/administration & dosage , Eicosapentaenoic Acid/chemistry , Male , Methylmercury Compounds/administration & dosage , Methylmercury Compounds/chemistry , Mice , Mice, Inbred C57BL
3.
Am J Physiol Endocrinol Metab ; 302(9): E1097-112, 2012 May 15.
Article in English | MEDLINE | ID: mdl-22338077

ABSTRACT

Fish oil rich in n-3 polyunsaturated fatty acids is known to attenuate diet-induced obesity and adipose tissue inflammation in rodents. Here we aimed to investigate whether different carbohydrate sources modulated the antiobesity effects of fish oil. By feeding C57BL/6J mice isocaloric high-fat diets enriched with fish oil for 6 wk, we show that increasing amounts of sucrose in the diets dose-dependently increased energy efficiency and white adipose tissue (WAT) mass. Mice receiving fructose had about 50% less WAT mass than mice fed a high fish oil diet supplemented with either glucose or sucrose, indicating that the glucose moiety of sucrose was responsible for the obesity-promoting effect of sucrose. To investigate whether the obesogenic effect of sucrose and glucose was related to stimulation of insulin secretion, we combined fish oil with high and low glycemic index (GI) starches. Mice receiving the fish oil diet containing the low-GI starch had significantly less WAT than mice fed high-GI starch. Moreover, inhibition of insulin secretion by administration of nifedipine significantly reduced WAT mass in mice fed a high-fish oil diet in combination with sucrose. Our data show that the macronutrient composition of the diet modulates the effects of fish oil. Fish oil combined with sucrose, glucose, or high-GI starch promotes obesity, and the reported anti-inflammatory actions of fish oil are abrogated. In conclusion, our data indicate that glycemic control of insulin secretion modulates metabolic effects of fish oil by demonstrating that high-GI carbohydrates attenuate the antiobesity effects of fish oil.


Subject(s)
Anti-Obesity Agents/therapeutic use , Dietary Carbohydrates/metabolism , Fish Oils/therapeutic use , Glycemic Index/physiology , Insulin/blood , Obesity/metabolism , Animals , Anti-Obesity Agents/metabolism , Dose-Response Relationship, Drug , Fish Oils/metabolism , Glucose , Male , Mice , Mice, Inbred C57BL , Obesity/chemically induced , Obesity/prevention & control , Sucrose
SELECTION OF CITATIONS
SEARCH DETAIL
...